The success of Viagra initially fueled a period of growth for pharma, but recent changes present a murky outlook for shareholders. Lower-cost alternatives are eroding revenue, and persistent litigation add additional https://nicoleymzm247901.bloguerosa.com/39857204/viagra-and-big-pharma-a-risky-bet